Showing material events only. Routine administrative filings — bylaw amendments, technical fund updates, procedural FD disclosures — are filtered out so the front page stays signal-dense.
8-K
Exec appointment
confidence 95%
filed 2026-06-17
Item 5.02
The Board elected Roelof Botha as an independent director effective immediately to fill an existing vacancy, and appointed him to the Audit Committee. The disclosure centers on the appointment of a new director with significant public company and audit committee experience, making this a clear exec_appointment event. The related family employment disclosure and indemnification agreement are ancillary to the principal action of taking a board role.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-17
Item 5.02
The filing discloses the appointment of Michael Feigin to CitroTech's board of directors on June 17, 2026, effective immediately, to fill one of two vacancies created by director resignations. While the section also reports the resignations of Theodore Ralston and Jeffery Pomerantz, the principal action disclosed is the appointment of a new director with detailed biographical information and committee assignments, making exec_appointment the most salient event. Board composition changes are material to investors assessing governance and oversight.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-17
EX-99.1
The press release announces the appointment of Maria Weaver as Chief Executive Officer and Board member of WeShop Holdings Limited, effective June 15, 2026. The disclosure explicitly states "its Board of Directors has appointed Maria Weaver as Chief Executive Officer and a member of the Board of Directors" and notes that she succeeds Paul Ellerbeck. This is a material executive appointment at the C-suite level, with detailed background on her 30-year career in media, entertainment, and technology, including senior roles at HBO, WMX, Comcast, and Interactive One.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-17
Item 5.02
John E. Gallagher has been appointed as Executive Vice President and Chief Financial Officer of CONMED Corporation, effective July 15, 2026, with a compensation package including a base salary of $650,000 and equity grants totaling approximately $3.8 million.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-16
Item 5.02
Jeremy M. Jacobs, Jr., CEO of Delaware North Companies, was elected to M&T Bank Corporation's Board of Directors on June 16, 2026. This is a clear executive appointment to the board of a major financial institution, which is material to investors assessing the company's governance and leadership composition.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-16
Item 5.02
The Board appointed Douglas Neal as an independent director effective immediately, increasing the Board size to seven members. Mr. Neal was also appointed to the Audit Committee and Compensation Committee.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-16
Item 5.02
The filing discloses the appointment of Dr. Matt Cohen as a director of Arrowhead Pharmaceuticals effective June 12, 2026. While the disclosure includes compensatory details (a sign-on grant of restricted stock units valued at $887,000), the principal action is the appointment itself. The extensive background information on Dr. Cohen's 25+ years of healthcare investing experience and his roles at major institutions (JP Morgan, Vida Ventures) underscores the materiality of adding a qualified director to the board.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-16
Item 5.02
B. Scot Ebron was appointed to the office of President of Shore United Bank, N.A. on June 15, 2026, and simultaneously appointed to the Bank's Board of Directors. This is a material executive appointment of a named officer to a senior leadership position at the Company's wholly-owned subsidiary, affecting the organizational structure and governance of the registrant.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-16
Item 5.02
The disclosure centers on the appointment of Bradley J. Pickard as a Class II director to FreightCar America's Board, effective June 10, 2026, with the Board size increasing to nine directors. This is a clear executive appointment event. While the section also mentions that Mr. Pickard will receive compensation "in accordance with the Company's non-executive director compensation policy," the principal disclosed action is the appointment itself, not a compensatory arrangement modification. The appointment is material as it affects board composition and governance.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-16
Per Narvinger has been appointed President and CEO of Ericsson effective October 1, 2026, by the Board of Directors. While the filing also discloses Börje Ekholm's departure as CEO on September 30, 2026, the principal announced action is the appointment of a new CEO to lead the company. This is a material executive appointment at the highest level of the organization.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-16
EX-99.1
The exhibit announces the appointment of Dirk Van de Put as AB InBev's new Chairman, effective 16 June 2026, succeeding Martin J. Barrington who retired. This is a material governance event involving the appointment of a director to a senior leadership position (Chairman). The disclosure explicitly states the Board "unanimously selected" Van de Put and provides his background and qualifications, which is characteristic of an executive appointment disclosure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-16
Item 5.02
The filing discloses the appointment of Jennifer Biry as Deputy Chief Financial Officer effective July 6, 2026, with her assuming the role of Senior Executive Vice President and Chief Financial Officer as of January 1, 2027. While Pascal Desroches's retirement is also mentioned, the principal disclosed action centers on Biry's appointment to a critical C-suite role. This is material as CFO succession at a major corporation affects investor assessment of financial leadership and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-16
Item 5.02
The Board elected Scott Sauer as a Class III Trustee on June 15, 2026, and appointed him to the Risk Committee. His compensation package includes an annual base retainer of $105,000, committee retainer of $7,750, and a one-time equity grant of $130,000 in restricted share units.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-16
Item 5.02
The filing discloses the appointment of Dr. Kathleen L. Kiernan to the Board of Directors as an independent director, effective June 15, 2026. The principal disclosed action is a person taking a role (director appointment), supported by detailed background on her qualifications, independence determination, and compensation terms. This is a material governance event affecting the composition of the Board.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-16
The filing discloses the appointment of Chance Moreland as Chief Financial Officer effective June 29, 2026. Item 5.02 explicitly covers this appointment, detailing his background at Morgan Stanley, educational credentials, compensation structure (base salary of $425,000, performance bonus up to 100%), and equity awards (523,211 RSUs and 523,211 PSUs). This is a material executive appointment to a named officer position.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-16
Item 5.02
Mr. W. Anthony (Tony) Will was appointed as a non-management Director of CRH PUBLIC LTD CO effective July 1, 2026, with the Board increasing from 12 to 13 members. The appointment was announced via press release on June 16, 2026.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-16
Item 5.02
GeneDx Holdings Corp. appointed Mark Gardner as President, effective June 15, 2026, with a $530,000 base salary, 65% target bonus, and $2,000,000 in restricted stock units vesting over four years.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-16
Item 5.02
The disclosure centers on the appointment of David M. Wisniewski as Chief Accounting Officer effective June 17, 2026, a material executive position responsible for accounting oversight. While the filing also includes compensatory details (base salary of $355,000, incentive awards, and equity grants valued at ~$700,000), the principal disclosed action is the appointment itself. The disclosure of Michael Kenning's transition from Interim CAO to Global Controller is secondary to the primary appointment event.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-16
Item 5.02
F&G Annuities & Life appointed Conor Murphy as Chief Executive Officer and President, succeeding Chris Blunt's retirement, and appointed Michael Bailey as Chief Financial Officer effective August 3, 2026, with Mark Wiltse serving as Interim CFO. This represents a significant leadership transition at the company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-15
Item 5.02
Adam B. Sefchick was appointed as Interim Chief Executive Officer and President effective June 15, 2026, following the immediate retirement of Christopher J. Reedy as CEO. The appointment addresses continuity of executive leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-15
Item 5.02
The Board appointed Steven B. Hedlund as a director effective September 10, 2026, and assigned him to the Audit Committee and Management Organization and Compensation Committee. This is a clear director appointment with committee assignments, which is material to investors as it affects board composition and governance. The disclosure of standard director compensation and pro-rated equity award is incidental to the principal appointment event.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-15
Item 5.02
The disclosure centers on the Board's approval of Lyndsey Crennen's appointment as Chief Accounting Officer, effective upon execution of her Employment Agreement. While the filing includes compensatory details (base salary of $325,000, bonus eligibility of 40%, and long-term incentive awards of $300,000 annually), the principal disclosed action is the appointment itself—a person taking a new executive role. The appointment of a Chief Accounting Officer is material to investors as it affects the company's financial reporting and internal control structure.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 85%
filed 2026-06-15
EX-99.1
The exhibit announces the appointment of Mr. Alfonso Duval as an interim Board member effective June 12, 2026, following the resignation of Mr. Pablo Echeverría Benítez. While both a departure and appointment occur, the principal disclosed action is Duval's appointment to the board. As a board-level governance change at a Nasdaq-listed asset manager, this is material to investors assessing the registrant's leadership and governance structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-15
Item 5.02
The disclosure centers on the appointment of Ryan D. Yost as Division President, Global Flexible Packaging Solutions, effective June 15, 2026, with detailed compensation terms including a $1,000,000 base salary, MIP participation, LTIP grants, a $175,000 sign-on bonus, and $1,600,000 in retention equity. While Fred Stephan's retirement is also disclosed, the substantive focus and length of the filing emphasizes Yost's appointment and compensation package, making this the principal event. The appointment of a senior division president with significant compensation arrangements is material to investors.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-15
Item 8.01
Kevin M. Bohl is assuming the responsibilities of General Counsel, Ethics & Compliance Officer and Corporate Secretary on an interim basis, expanding his executive role from Senior Vice President, Deputy General Counsel and Assistant Corporate Secretary.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-15
Item 5.02
Jason Tremblay was appointed as Chief Financial Officer of Intrepid Potash, Inc., effective immediately on June 15, 2026, replacing interim principal financial officer Cris Ingold. The appointment includes a base salary of $435,000, a bonus target of 75%, and equity grants totaling $600,000.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 80%
filed 2026-06-15
Item 5.02
Samantha L. Hammock was appointed as Executive Vice President and Chief Human Resources Officer, effective July 13, 2026, succeeding Silvana Battaglia who retired from the role effective July 12, 2026. Ms. Hammock joins from Verizon, bringing external leadership to the company's human resources function.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-15
Item 5.02
Newmont appointed four senior executives to key C-suite roles effective July 1, 2026: Mark Rodgers as Chief Operating Officer, David Thornton as Chief Technical Officer, Brian Tabolt as Chief Financial Officer, and Joshua Cage as Chief Accounting Officer. These material appointments to principal officer positions are disclosed under the leadership restructuring under CEO Natascha Viljoen.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-15
Item 8.01
The Board re-appointed Francis M. Scricco as non-executive Chairman on June 11, 2026, a significant governance event reflecting leadership continuity.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 95%
filed 2026-06-15
EX-99.1
ING announced the appointment of Hilde Garssen to the Management Board Banking as chief human resources officer (CHRO), effective 1 September 2026. This is a clear executive appointment to a senior leadership role on the Management Board. The disclosure notes that the CHRO role has been elevated to the Management Board level, reflecting strategic importance, and the appointment has been approved by the European Central Bank, indicating material governance significance.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-06-15
EX-99.1
The press release's primary disclosure is the appointment of Mika Grasso as Co-CEO, responsible for finance and public markets. The release states "Ongoing evaluation of our corporate team and issuer status has provided the opportunity to further enhance our c-suite effectiveness and to optimize our public markets efficiency with the addition of Mika Grasso as co-CEO." This is a material executive appointment affecting the registrant's leadership structure and governance, with detailed biographical information provided. While the release also discusses corporate strategy and drug development programs, the headline and substantive focus is the executive appointment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-15
Item 5.02
Michael P. Lyons appointed as CEO and President of Truist Financial Corporation and Truist Bank effective September 1, 2026, with base salary of $1,300,000, target AIP of 325%, and LTI awards totaling $12,000,000 for 2026 plus substantial replacement awards. William H. Rogers, Jr. retired as CEO and transitioned to Executive Chair.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-15
Item 5.02
Sensei Biotherapeutics appointed Anand Parikh as President and Chief Executive Officer (promoted from COO), Brian Stephenson as Chief Financial Officer, and Josiah Craver as Senior Vice President of Finance and principal accounting officer, all effective June 13, 2026. Additionally, Stephen M. Hahn and Saira Ramasastry were appointed as new directors on June 12, 2026. These appointments represent material changes to the company's executive and board leadership structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-15
Item 5.02
Takis Georgakopoulos was appointed as Chief Executive Officer and Board member on June 14, 2026, following the resignation of Michael P. Lyons on June 12, 2026. The appointment includes a compensation package of $1.3M base salary, $18.6M annual equity opportunity, and $6M in promotion equity awards.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-15
Item 8.01
Dr. William Grossman was appointed as Interim Chief Medical Officer effective June 15, 2026, and Kathleen Richton was appointed as principal financial officer, filling key C-suite positions following recent executive departures.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-15
Item 5.02
Elliott Rodgers was appointed Chief Operating Officer of Kohl's Corporation, effective September 9, 2026. While the disclosure includes detailed compensatory arrangements (salary of $900,000, signing incentive of $400,000, long-term incentive target of $2,500,000, and other benefits), the principal disclosed action is the appointment of a named executive to a C-suite officer role. This is material to investors as it signals a significant leadership change at a major retailer.
View raw filing on EDGAR →
6-K
Exec appointment
confidence 92%
filed 2026-06-15
The filing discloses the appointment of Mr. Wong Tai Kok as an Independent Director and Chair of the Nomination Committee effective June 12, 2026, approved by the Board, Nomination Committee, and Compensation Committee. While the filing also mentions Mr. Henliyanto Ngadini's resignation, the principal disclosed action is the appointment of a new director to a leadership role (Chair of Nomination Committee), making exec_appointment the primary classification. The appointment includes compensation terms (US$10,000 annually) and biographical information, consistent with standard director appointment disclosures.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-15
Item 5.02
The filing discloses the appointment of Andrew Farag as Chief Financial Officer, principal accounting officer, Executive Vice President, and Treasurer, effective June 15, 2026. While the section also includes Keith Siegner's resignation as CFO, the primary focus and substantive disclosure centers on Farag's appointment with detailed background, compensation terms ($560,000 base salary, $791,000 annual RSU grant, $255,000 signing bonus, and $450,000 one-time RSU grant), and employment agreement terms. This is a material executive appointment affecting the company's financial leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 94%
filed 2026-06-15
Item 5.02
Pradip Patiath was appointed as a member of the Board of Directors of AXIS CAPITAL HOLDINGS LTD effective June 15, 2026, with assignment to the Risk and Human Capital and Compensation Committees.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 90%
filed 2026-06-15
Item 5.02
Alexandre I. Ruberti was appointed President and Chief Executive Officer of Zevia PBC effective June 15, 2026, succeeding Amy E. Taylor. The appointment includes a base salary of $638,000, equity awards totaling $1.8M in 2026, and severance provisions, representing a material executive succession affecting the company's leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-15
Item 5.02
The filing discloses the appointment of Shanker Trivedi to the Board of Directors effective June 11, 2026, with the Board increasing from seven to eight directors. While the disclosure also includes compensatory arrangements (a $250,000 RSU award and standard director compensation), the principal action is the appointment itself. Trivedi's extensive enterprise technology and sales leadership experience at NVIDIA and prior roles make this a material board composition change for a solar/energy technology company.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 92%
filed 2026-06-15
The filing discloses the appointment of Michael L. Hrynuik as Chief Financial Officer effective June 15, 2026, along with the concurrent resignation of prior principal accounting officer Scott M. Boruff. While both a departure and appointment occur, the principal disclosed action centers on the appointment of a new CFO with detailed background and an employment agreement providing for base salary, bonus, and a 2,000,000 share restricted stock award. This is material to investors as CFO changes affect financial oversight and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-15
Item 5.02
The principal disclosed action is the appointment of Doug Cogan as President of the Company, effective June 9, 2026, while he continues as CEO. Although the filing also discloses a new employment agreement with compensation terms (base salary of $240,000, bonus eligibility, and a 2,500,000 share restricted stock award), the core event is the executive appointment. The appointment of a sitting CEO to the additional role of President is a material change in executive structure that would affect a reasonable investor's assessment of the company's governance and leadership.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-15
Item 5.02
Mr. Pascal Desroches was appointed as an Independent Director and Audit Committee chair of Honeywell Aerospace Inc., effective June 14, 2026, a material governance change affecting board composition and oversight.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 75%
filed 2026-06-15
Item 1.01
The filing discloses entry into a Vice Chairman Agreement with Mark Iwanowski, appointing him to serve as Vice Chairman in an advisory capacity effective June 12, 2026. Although the position is non-executive and advisory (not a Board seat or officer role under the Exchange Act), the appointment of a high-profile strategic advisor with substantial technology and M&A experience to a named executive-level position is material to investors assessing the company's leadership and strategic direction. The equity compensation structure ($150,000 annual NSOs plus performance-based grants) reinforces the materiality of this appointment.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-15
Item 5.02
The disclosure centers on the appointment of Andrew Taylor as Vice President and Chief Accounting Officer effective August 28, 2026, a material executive position. While S. Denise Sumner's retirement is also disclosed, the filing's substantive focus is on Taylor's appointment with detailed background information (prior PWC experience, credentials, and confirmations of no conflicts). The Chief Accounting Officer role is material to investors' assessment of financial reporting oversight and internal controls.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-15
Item 5.02
The Board appointed Andrew Gengos as Chief Financial Officer and Treasurer, effective on or before July 16, 2026, succeeding Mallory Morales in the principal financial officer role. While the disclosure also includes compensatory arrangements (base salary of $530,000, 40% target bonus, and 650,000 option grant), the principal disclosed action is the appointment of a named executive officer to a key financial leadership position. This is material to investors as CFO changes affect financial oversight and strategy.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-15
Item 5.02
The filing discloses the appointment of Laura Boettcher as Chief Operating Officer of Hippo Holdings Inc., effective June 10, 2026. While the disclosure also includes compensatory details (base salary of $450,000, bonus eligibility, and equity grants), the principal action is her appointment to a C-suite officer role. The appointment of a COO is material to investors as it reflects organizational leadership changes and operational oversight structure.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 95%
filed 2026-06-12
Item 5.02
The filing discloses the election of Vishal Talwar as a director of Fastenal Company effective June 12, 2026, increasing the Board from eleven to twelve members. Mr. Talwar, currently Executive Vice President and Chief Digital and Information Officer at FedEx Corporation, was also appointed to the Nominating and Corporate Governance Committee. This is a clear director appointment that would be material to investors assessing Board composition and governance.
View raw filing on EDGAR →
8-K
Exec appointment
confidence 85%
filed 2026-06-12
Item 5.02
Val Bauduin was designated as Starbucks' principal accounting officer on June 11, 2026, with principal accounting officer responsibility transferring from CFO Cathy Smith to Bauduin. While Bauduin retains his existing SVP title and compensation, the designation of a principal accounting officer is a material executive appointment affecting the company's financial reporting structure and governance. The disclosure emphasizes his background as controller and chief accounting officer at Marriott, underscoring the significance of this accounting leadership role.
View raw filing on EDGAR →